| Health / Medical Topics |
Monoclonal Antibody CEP-37250/KHK2804
A humanized monoclonal antibody targeting glycolipids, with potential immunomodulating and antineoplastic activity. Upon administration, monoclonal antibody CEP-37250/KHK2804 targets and binds to a specific tumor antigen, thereby stimulating the immune system to exert an antibody-dependent cellular cytotoxicity (ADCC) against the tumor associated antigen (TAA)-expressing cancer cells. This agent has shown to be active in both wild-type and mutant K-RAS-expressing colorectal cancer cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A monoclonal antibody directed against carcinoembryonic antigen (CEA) which is expressed by most gastrointestinal carcinomas and by some breast, lung and ovarian…
A mouse anti-human CD19 monoclonal antibody (MoAb). CD19 as well as CD22 are cell surface antigens present on a majority of B…
A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72…
A second-generation murine monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed…
A second-generation murine monoclonal antibody based on the monoclonal antibody B72.3 and directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed…
A second-generation murine monoclonal antibody based on monoclonal antibody B72.3 and directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed in…
